Physician profile
Ericka Glass
NPI 1275746570
$6,292.70
in general payments reported to CMS, 2019-2025
16 companies · $563 in 2025
The $563 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,920 · 2020: $762 · 2021: $230 · 2022: $1,043 · 2023: $428 · 2024: $1,347 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,814 · Travel and Lodging: $427 · Education: $96.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,814.28 |
| Travel and Lodging | $427.35 |
| Education | $96.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,672.64 | 2021-2025 | T2 Alpha, Insignia, Pro |
| Arthrex, INC. | $1,702.35 | 2019-2024 | |
| Rock Medical Orthopedics, INC. | $689.73 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $579.15 | 2019-2020 | |
| Depuy Synthes Sales INC. | $146.85 | 2020-2025 | Monovisc |
| Convatec INC. | $111.57 | 2023 | |
| Wright Medical Technology, INC. | $90.11 | 2020 | |
| Hydrocision, INC. | $71.44 | 2023 | Tenjet |
| Aroa Biosurgery Incorporated | $45.99 | 2024 | |
| Smith+Nephew, INC. | $43.77 | 2019 | |
| Sanofi-Aventis U.S. LLC | $34.19 | 2019-2020 | |
| Kerecis Limited | $30.68 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Endo Pharmaceuticals INC. | $25.04 | 2020 | |
| Orthofix Medical, INC. | $22.29 | 2019 | |
| Medtronic, INC. | $14.27 | 2023 | Intellis Adaptivestim |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $12.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ericka Glass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.